Search

Editors

Richard L. Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Michael Scher
Senior Editor

Elizabeth K. Spahn Contributing Editor

Julie DiMauro Contributing Editor

Eric Carlson Contributing Editor

Michael Kuria Contributing Editor

Thomas Fox Contributing Editor

Philip Fitzgerald Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Connect

Subscribe to receive the free FCPA Blog daily

Close
FCPA Blog Daily News

« The SFO's Red Flags | Main | Ron James And The Center For Ethical Business Cultures »
Tuesday
Nov222011

What The Pharmas Are Reading

The latest issue of the Rx Compliance Report included  summaries of our posts, a flock of pharmas and why benchmarking matters.

We're happy to be included. Most of the forty drug companies subscribe to the newsletter, as do the law firms that help them. For ten years, Rx Compliance has been chronicling the 'government's crackdown on pharmaceutical sales and marketing practices.' That crackdown is gaining speed.

The Wall Street Journal reported this week that Pfizer will pay about $60 million to settle alleged FCPA violations. In April, Johnson & Johnson resolved FCPA offenses by paying $70 million.

Our 2011 corporate investigations list included Pfizer, as well as AstraZeneca, Biomet, Bio-Rad Laboratories, Bristol-Meyers Squibb, Covidien, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Orthofix International, Sciclone Pharmaceuticals, Smith & Nephew, Stryker Corporation, Talecris Biotherapeutics, and Zimmer.

The same issue of Rx Compliance ran a front-page story about Jeff Kaplan's view of global enforcement trends. Kaplan, co-author of the anti-corruption compliance program benchmarking survey, also described 'five practical benchmarks in anti-corruption efforts.'

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
All HTML will be escaped. Hyperlinks will be created for URLs automatically.